We are thrilled to announce that SPOT Protocol, a subsidiary of Ampleforth, has successfully raised $1,000,000 in funding. Ampleforth is a pioneering digital asset protocol dedicated to creating fair and independent money solutions. This recent funding will be instrumental in advancing the development and implementation of SPOT Protocol's innovative technologies in the digital asset space. The company's commitment to reshaping the landscape of decentralized finance and providing users with reliable, transparent financial solutions is truly commendable. With this latest injection of capital, SPOT Protocol is poised to continue its mission of revolutionizing the digital asset industry and delivering cutting-edge financial services to a global audience.
.png&w=3840&q=75)
SPOT Protocol (Ampleforth) Secures $1 Million in Funding for Future Growth
Recently funded 路 $1.0MFinance
Get the full SPOT Protocol (Ampleforth) company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
